Related references
Note: Only part of the references are listed.Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve
Engin Turkgeldi et al.
HUMAN FERTILITY (2022)
Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses
Baris Ata et al.
HUMAN REPRODUCTION UPDATE (2021)
Endometrial thickness is not predictive for live birth after embryo transfer, even without a cutoff
Bahar Shakerian et al.
FERTILITY AND STERILITY (2021)
Progesterone is a physiological trigger of ovulatory gonadotropins
Dmitri Dozortsev et al.
FERTILITY AND STERILITY (2020)
Subcutaneous versus vaginal progesterone for vitrified-warmed blastocyst transfer in artificial cycles
Engin Turkgeldi et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2020)
Haste makes waste: don't rush for a fresh embryo transfer in high responders
Baris Ata
HUMAN REPRODUCTION (2020)
Ovarian response in oocyte donation cycles under LH suppression with GnRH antagonist or desogestrel progestin: retrospective and comparative study
Francisca Martinez et al.
GYNECOLOGICAL ENDOCRINOLOGY (2019)
Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology
Sule Yildiz et al.
FERTILITY AND STERILITY (2019)
Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
Qiuju Chen et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology
Nanako Iwami et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2018)
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation
Xiuxian Zhu et al.
FERTILITY AND STERILITY (2017)
Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a freeze all'' strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg
Xiuxian Zhu et al.
FERTILITY AND STERILITY (2017)
Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists - a randomized study
E. Bosch et al.
HUMAN REPRODUCTION (2008)
Share Paper
